Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region ForumsFDA Approves Marijuana-Based Epilepsy Drug For Use On Kids In Clinical Trials
Federal regulators have approved two clinical studies testing whether a marijuana-based epilepsy drug may help prevent seizures among epileptic children.
In San Francisco and New York City, the physician-led pediatric studies will assess the viability of a purified cannabidiol as an anti-seizure treatment among patients with various forms of epilepsy. Although both studies will enroll 25 patients initially, the U.S. Food and Drug Administration (FDA) may approve more as the studies progress.
Drs. Roberta Cilio and Orrin Devinsky, of the University of California, San Francisco and New York University, respectively, will investigate the use of Epidiolex, a 98 percent purified cannabidiol drug manufactured by GW Pharmaceuticals, of the United Kingdom. Cilio will also conduct two individual studies of the drug.
Geoffrey Guy, chairman of the pharmaceutical company, told reporters that the purified drug contains no tetrahydrocannabinol (THC), the psychotropic ingredient in marijuana causing the recreational high. Our definition of pure is no THC, Guy said, adding that clinical study would help provide better understanding and experience in what cannabidiol does in these different children groups, what benefit we can see, and how the results can best be measured.
In San Francisco and New York City, the physician-led pediatric studies will assess the viability of a purified cannabidiol as an anti-seizure treatment among patients with various forms of epilepsy. Although both studies will enroll 25 patients initially, the U.S. Food and Drug Administration (FDA) may approve more as the studies progress.
Drs. Roberta Cilio and Orrin Devinsky, of the University of California, San Francisco and New York University, respectively, will investigate the use of Epidiolex, a 98 percent purified cannabidiol drug manufactured by GW Pharmaceuticals, of the United Kingdom. Cilio will also conduct two individual studies of the drug.
Geoffrey Guy, chairman of the pharmaceutical company, told reporters that the purified drug contains no tetrahydrocannabinol (THC), the psychotropic ingredient in marijuana causing the recreational high. Our definition of pure is no THC, Guy said, adding that clinical study would help provide better understanding and experience in what cannabidiol does in these different children groups, what benefit we can see, and how the results can best be measured.
http://www.medicaldaily.com/fda-approves-marijuana-based-epilepsy-drug-use-kids-clinical-trials-261998
Medical researchers believe cannabidiol provides therapeutic benefit by interacting with receptors in the brain and spinal cord. During the past couple of decades, investigators have discovered two different types of cannabinoid receptors in the brain, spinal cord, and peripheral tissues, including immune tissues. Scientists say the cannabinoid system interacts with many other neurotransmitter/neuromodulator systems for a reach that extends nearly throughout the body.
Moreover, researchers say current knowledge of the cannabinoid system suggests the existence of other cannabinoid receptors yet to be discovered.
Moreover, researchers say current knowledge of the cannabinoid system suggests the existence of other cannabinoid receptors yet to be discovered.
InfoView thread info, including edit history
TrashPut this thread in your Trash Can (My DU » Trash Can)
BookmarkAdd this thread to your Bookmarks (My DU » Bookmarks)
8 replies, 1762 views
ShareGet links to this post and/or share on social media
AlertAlert this post for a rule violation
PowersThere are no powers you can use on this post
EditCannot edit other people's posts
ReplyReply to this post
EditCannot edit other people's posts
Rec (10)
ReplyReply to this post
8 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
FDA Approves Marijuana-Based Epilepsy Drug For Use On Kids In Clinical Trials (Original Post)
Jesus Malverde
Nov 2013
OP
Fridays Child
(23,998 posts)1. This is good news!
Another brick kicked out of the wall of prohibition.
CaliforniaPeggy
(149,593 posts)2. This is about time!
RainDog
(28,784 posts)3. An important step
Congress needs to remove mj from the schedule I now.
Do do anything else just illustrates the corruption of science, yet again, because of conservative ideology.
It's getting tiresome...
KT2000
(20,577 posts)4. why pharmaceuticals?
As I understand it, certain strains of mj can be made into a tea that is effective for reducing seizures in children.
Consistant doseages will result in better control.
You can't get that with tea.
solarhydrocan
(551 posts)5. Does this fall under the US Patent on Cannabinoid use?
Cannabinoids as antioxidants and neuroprotectants
United States Patent 6,630,507
Hampson , et al. October 7, 2003 <-----------NOTE DATE
Assignee: The United States of America as represented by the Department of Health and Human Services (Washington, DC)
Abstract
Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia.
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6630507.PN.&OS=PN/6630507&RS=PN/6630507
Yeah great, if you get to sell it with Patent Protection. like Kannalife
While closing dispensaries and arresting caregivers, the US Gov patented the use of the main ingredient in Pot.
And there's others:
US Patent 4189491 - Tetrahydrocannabinol in a method of treating glaucoma
(full - 1980)
http://www.patentstorm.us/patents/4189491.html
Click for 20+ more
https://sites.google.com/site/gscmmjlist/home/a/p/patents-related-to-cannabis
United States Patent 6,630,507
Hampson , et al. October 7, 2003 <-----------NOTE DATE
Assignee: The United States of America as represented by the Department of Health and Human Services (Washington, DC)
Abstract
Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia.
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6630507.PN.&OS=PN/6630507&RS=PN/6630507
Yeah great, if you get to sell it with Patent Protection. like Kannalife
While closing dispensaries and arresting caregivers, the US Gov patented the use of the main ingredient in Pot.
And there's others:
US Patent 4189491 - Tetrahydrocannabinol in a method of treating glaucoma
(full - 1980)
http://www.patentstorm.us/patents/4189491.html
Click for 20+ more
https://sites.google.com/site/gscmmjlist/home/a/p/patents-related-to-cannabis
sakabatou
(42,152 posts)6. I wonder how good it is against other anti-epilepsy drugs
grahamhgreen
(15,741 posts)7. Known as CBD. See Dr Franklins work.